Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magré, J.
Right arrow Articles by Lathrop, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magré, J.
Right arrow Articles by Lathrop, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:1573-1578, 2003
© 2003 by the American Diabetes Association, Inc.


Brief Genetics Reports

Prevalence of Mutations in AGPAT2 Among Human Lipodystrophies

Jocelyne Magré1, Marc Delépine2, Lionel Van Maldergem3, Jean-Jacques Robert4, J. Antonie Maassen5, Muriel Meier1, Vanessa R. Panz6, Chong Ae Kim7, Nadia Tubiana-Rufi8, Paul Czernichow8, Eva Seemanova9, Charles R. Buchanan10, Didier Lacombe11, Corinne Vigouroux1, Olivier Lascols1, C. Ronald Kahn12, Jacqueline Capeau1, and Mark Lathrop2

1 INSERM U.402, Saint-Antoine Faculty of Medicine, University of Pierre and Marie Curie, Paris, France
2 National Center of Genotyping, Evry, France
3 Center of Human Genetics, Institute of Pathology and Genetics, Loverval, Belgium
4 Department of Pediatric Diabetology, Necker Hospital, Paris, France
5 Sylvius Laboratory, University of Leiden Medical Center, Leiden, the Netherlands
6 Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa
7 Department of Pediatrics, da Crianca Institute, University of Sao Paulo, Sao Paulo, Brazil
8 Department of Pediatric Endocrinology, Robert Debré Hospital, Paris, France
9 Department of Clinical Genetics, Charles University, Prague, Czech Republic
10 Department of Child Health, King’s College Hospital, London, U.K
11 Department of Medical Genetics, Pellegrin-Enfants Hospital, Bordeaux, France
12 Joslin Diabetes Center, Harvard University, Boston, Massachusetts

Berardinelli-Seip congenital lipodystrophy (BSCL) is a heterogeneous genetic disease characterized by near absence of adipose tissue and severe insulin resistance. We have previously identified mutations in the seipin gene in a subset of our patients’ cohort. Recently, disease-causing mutations in AGPAT2 have been reported in BSCL patients. In this study, we have performed mutation screening in AGPAT2 and the related AGPAT1 in patients with BSCL or other forms of lipodystrophy who have no detectable mutation in the seipin gene. We found 38 BSCL patients from 30 families with mutations in AGPAT2. Three of the known mutations were frequently found in our families. Of the eight new alterations, six are null mutations and two are missense mutations (Glu172Lys and Ala238Gly). All the patients harboring AGPAT2 mutations presented with typical features of BSCL. We did not find mutations in patients with other forms of lipodystrophies, including the syndromes of Lawrence, Dunnigan, and Barraquer-Simons, or with type A insulin resistance. In conclusion, mutations in the seipin gene and AGPAT2 are confined to the BSCL phenotype. Because we found mutations in 92 of the 94 BSCL patients studied, the seipin gene and AGPAT2 are the two major genes involved in the etiology of BSCL.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
V. A. Payne, W.-S. Au, S. L. Gray, E. D. Nora, S. M. Rahman, R. Sanders, D. Hadaschik, J. E. Friedman, S. O'Rahilly, and J. J. Rochford
Sequential Regulation of Diacylglycerol Acyltransferase 2 Expression by CAAT/Enhancer-binding Protein beta (C/EBPbeta) and C/EBP{alpha} during Adipogenesis
J. Biol. Chem., July 20, 2007; 282(29): 21005 - 21014.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. Lu, A. H. Moser, J. K. Shigenaga, K. R. Feingold, and C. Grunfeld
Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response
J. Lipid Res., October 1, 2006; 47(10): 2179 - 2190.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Vergnes, A. P. Beigneux, R. Davis, S. M. Watkins, S. G. Young, and K. Reue
Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity
J. Lipid Res., April 1, 2006; 47(4): 745 - 754.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. P. Beigneux, L. Vergnes, X. Qiao, S. Quatela, R. Davis, S. M. Watkins, R. A. Coleman, R. L. Walzem, M. Philips, K. Reue, et al.
Agpat6--a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium
J. Lipid Res., April 1, 2006; 47(4): 734 - 744.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Garg
Acquired and Inherited Lipodystrophies
N. Engl. J. Med., March 18, 2004; 350(12): 1220 - 1234.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. B. Gomes, A. P. Fernandes, A. C. S. Ferreira, H. Pardini, A. Garg, J. Magre, and V. C. Pardini
Mutations in the Seipin and AGPAT2 Genes Clustering in Consanguineous Families with Berardinelli-Seip Congenital Lipodystrophy from Two Separate Geographical Regions of Brazil
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 357 - 361.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.